Evidence map›Paper›PMID 15794909›Full record

ReviewCurrent diabetes reports2005

Polyendocrine autoimmunity.

Jennifer M Barker

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current diabetes reports, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Jennifer M BarkerBarbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 E. 9th Avenue Box B140, Denver, CO 80262, USA. jennifer.barker@uchsc.edu
University of Colorado Health · US

Funding

ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · NCRR · UNIVERSITY OF COLORADO DENVER · PI KOSMISKI, LISA A. · 1985 to 2008
$52.6M
ZORVIRAX ORAL SUSPENSION FOR SEVERE CHILDHOOD HERPES VIRUS INFECTIONSM01RR000069 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 1985 to 2008
$22.1M
MHC peptide tetramers in type 1 diabetesU19AI046374 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLERS, VERNON MICHAEL · 1999 to 2007
$9.6M
Natural History of Pre-Diabetic Autoimmunity (DAISY)R01DK032493 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI REWERS, MARIAN J · 1986 to 2024
$9.3M
Natural History of Pre-diabetic Autoimmunity (DAISY)R37DK032493 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI REWERS, MARIAN J · 2001 to 2010
$8.0M
Multiple Autoantigens/Multiple Epitopes of Type 1DMR01DK032083 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI MICHELS, AARON W · 1986 to 2025
$6.9M
IN VIVO NOD EVALUATION OF A PATHOGENIC INSULIN PEPTIDER01DK055969 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI EISENBARTH, GEORGE S · 1998 to 2009
$2.2M
ANTIBODIES TO RECOMBINENT AUTOANTIGENS--PREDICTR01AI039213 · NIAID · UNIVERSITY OF COLORADO DENVER · PI EISENBARTH, GEORGE S · 1996 to 2004
$1.4M
IMMUNOTHERAPY TRIAL IN NEW ONSET TYPE 1 DIABETESR01DK059097 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI GOTTLIEB, PETER A · 2000 to 2002
$1.0M
Human TCR/HLA Transgenic Mice to Prevent T1DMR21DK063518 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI GOTTLIEB, PETER A · 2002 to 2003
$693k
Modeling and Detecting Pathogens of Islet AutoimmunityR01DK062718 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI EISENBARTH, GEORGE S · 2002 to 2005
$611k
COLLABORATIVE NETWORK FOR CLINICAL RES ON IMMUNE TOLERANN01AI095380 · NIAID · UNIVERSITY OF CHICAGO · PI BLUESTONE, JEFFREY A · 1999 to 2000
$240k
NCRR NIH HHS M01 RR00069NCRR NIH HHS M01 RR0051NIAID NIH HHS AI39213NIAID NIH HHS AI46374NIAID NIH HHS AI95380NIDDK NIH HHS DK32083NIDDK NIH HHS DK32493NIDDK NIH HHS DK55969NIDDK NIH HHS DK59097NIDDK NIH HHS DK62718NIDDK NIH HHS DK63518NIDDK NIH HHS DK71926
6 · The paper itself

Abstract

Autoimmune polyendocrine disorders are characterized by the presence of more than one autoimmune endocrine disease. Study of such disorders has provided unique insight into the pathogenesis of autoimmunity and the development of tolerance in the normal individual. Autoimmune polyendocrine syndromes I and II have distinctive inheritance patterns, genetic causes, component diseases, and implications for follow-up. Care for individuals with these diseases requires monitoring for additional autoimmune disorders and aggressive treatment of identified diseases to prevent morbidity and mortality in affected individuals.

Indexed as

Autoimmune DiseasesEndocrine System DiseasesHumansImmune Tolerance

Identifiers

PMID15794909
OpenAlexW3190518197

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.